Showing 4991-5000 of 5554 results for "".
- Cipher Pharmaceuticals Acquires Innocutishttps://practicaldermatology.com/news/cipher-pharmaceuticals-acquires-innocutis/2458969/Cipher Pharmaceuticals Inc. has acquired Innocutis Holdings LLC, a privately held specialty dermatology company, for US$45.5 million in cash. (All financial references are in U.S. dollars unless otherwise noted.) "This acquisition marks our commercial entry to the U.S. market an
- FixMySkin Unveils New Lookhttps://practicaldermatology.com/news/fixmyskin-unveils-new-look/2458974/FixMySkin Healing Balms with 1% Hydrocortisone have a new look with the same great formula. Now available in environmentally friendly packaging, these balms come in two convenient sizes for the lips and body. Th
- Novan Secures $50 Million Private Financinghttps://practicaldermatology.com/news/novan-secures-50-million-private-financing/2458973/Novan Therapeutics, a clinical-stage biotechnology company focused on advancing innovation in dermatology via nitric oxide therapies, today announced that it has secured $50 million in an oversubscribed private financing. New investor Malin Corporation Plc. (MLC: ISE) functioned as the cornerston
- New Officers Assume Roles with the American Academy of Dermatologyhttps://practicaldermatology.com/news/new-officers-assume-roles-with-the-american-academy-of-dermatology/2458976/Mark Lebwohl, MD, FAAD, a dermatologist in New York City, took office as president of the American Academy of Dermatology (AAD). Timothy G. Berger, MD, FAAD, a dermatologist in San Francisco, also assumed his position as vice president of the AAD. Drs. Lebwohl and Berger assumed office at the con
- Promius Pharma Launches Zenatane 30mg Dosehttps://practicaldermatology.com/news/promius-pharma-launches-zenatane-30mg-dose/2458977/Promius Pharma, LLC has announced that ZENATANE™(Isotretinoin Capsules USP) are now available in a 30mg dose. Zenatane, AB rated equivalent to Accutane 30mg, has been introduced in response to dermatologists who have continued to request this strength of the drug. <
- Signum Dermalogix Out-Licenses SIG990 to Dermata Therapeutics for Topical Treatment of Rosaceahttps://practicaldermatology.com/news/signum-dermalogix-out-licenses-sig990-to-dermata-therapeutics-for-topical-treatment-of-rosacea/2458979/Signum Dermalogix, Inc. entered into an agreement with Dermata Therapeutics to develop a topical product for the treatment of patients with rosacea. SIG990 is a novel, first-in-class anti-inflammatory compound, which has the potential to both reduce erythema and decrease the papules and pustules
- Nextech Systems and Iagnosis Showcase New Partnershiphttps://practicaldermatology.com/news/nextech-systems-and-iagnosis-showcase-new-partnership/2458982/Nextech, a leading provider of specialty-focused healthcare technology solutions for physician practices, announced an exclusive partnership with Iagnosis, a leading telemedicine provider of online dermatology solutions. Iagnosis provides a teledermatolog
- NeoStrata® Launches SKIN ACTIVE Dermal Replenishmenthttps://practicaldermatology.com/news/neostrata-launches-skin-active-dermal-replenishment/2458980/NeoStrata Company, Inc., today announced the launch of SKIN ACTIVE Dermal Replenishment, an intense hydrator that delivers a powerful four-pronged anti-aging approach. Created to synergistically replenish optimal hydration levels and reverse signs of a
- Suneva Medical Introduces Regenica Recovery Gelhttps://practicaldermatology.com/news/suneva-medical-introduces-regenica-recovery-gel/2458983/Suneva Medical, Inc. introduced Regenica® Recovery Gel, a new addition to the Regenica® skin care system, during the American Academy of Dermatology Annual Meeting. Regenica® Recovery Gel is a soothing balm that is specially formulated to help quickly heal damaged skin. It infuses Mul
- NuGene BioPharma, Inc. Acquires SkinGuardian®https://practicaldermatology.com/news/nugene-biopharma-inc-acquires-skinguardian/2458986/NuGene International, Inc.’s subsidiary corporation, NuGene BioPharma, Inc., has acquired all rights, title and interest in and to SkinGuardian®, an FDA-approved (monographed) skin protectant, antiseptic, and moisturizing topical cream. NuGene BioPharma acquired all intellectual